| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.089 | 0.003 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.004 |
| mRNA | PD318088 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.004 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.089 | 0.004 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.085 | 0.005 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.094 | 0.005 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.092 | 0.006 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.087 | 0.006 |